Measure

Every individual or entity that imports, exports, produces, or manufactures medicines containing Schedule 4 or specified Schedule 3 substances must submit an annual return to the Registrar by February 28. This return must include: (a) the quantity of the substance held in stock as of December 31 of the previous year; (b) the quantity acquired during the previous year through importation, production, or manufacture of raw materials or preparations; and (c) the quantity disposed of during that year.

32. (1) Every person who imports, exports, produces or manufactures a medicine containing, or consisting of, a Schedule 4 substance or such Schedule 3 substances, as may be specified by the Registrar by notice in the Gazette, must submit to the Registrar, on or before 28 February of each year, a return containing -
(a) the quantity of such substance as was held in stock on 31 December of the preceding calendar year;
(b) the quantity of such substance acquired during the preceding calendar year by the importation, production or manufacture of -
(i) any raw material of such substance;
(ii) any preparations of such substance;
(c) the quantity of such substance which was disposed